Sub-microliter volumes are hard to draw accurately, so transfers come up short.
Samples cling to the tip instead of releasing, leaving delivery incomplete.
Dragging the tip along a vessel wall introduces operator-to-operator error.
Contact dispensing and carryover raise the risk of well-to-well contamination.
Inaccuracy drives duplicates and triplicates, burning through costly reagents.
Miniaturized assays lose consistency exactly where precision matters most.
Fast, accurate transfers across large campaigns.
Contact-free delivery into dense plate formats.
Gentle, precise dosing for sensitive cell work.
Reproducible small-volume steps for clinical workflows.
Precise reagent metering for library prep.
Consistent low-volume additions for ELISA and beyond.
Differential cores for integration into instruments.
Shrink reactions and reagent cost without losing accuracy.
The world’s first multichannel Differential Pipettor™ — nanoliter aspiration with built-in high-flow, contact-free blow-off.
A precision system for ultra-small volumes down to nanoliters that still moves large volumes fast when needed.
Handheld Differential Pipetting™ for fast, intuitive, contact-free transfers at the bench.
Catalytic Stage 1 Private Placement
4,343 common shares have been subscribed. An additional 700 shares are reserved for cancellation of $12,000 in debt under the same terms; the remaining balance is expected from 9,542 reserved shares.
Stage 2 private placements are anticipated at $2 million in 2027 and $3 million in 2028.
Request current investor materials →Company-supplied placement status. Terms are subject to definitive offering materials, availability, and applicable securities laws.
01 · Patented technology
Three issued U.S. patents protect the core differential mechanism.
02 · Large, layered market
Lab automation, life-science tools, diagnostics, and screening.
03 · Multiple business models
Product sales, OEM modules, licensing, and strategic partnerships.
04 · Live momentum
SLAS 2026 visibility, product demonstrations, and active partner conversations.